A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3)

PHASE3CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

March 31, 2010

Conditions
Periodontitis
Interventions
DRUG

Trafermin

Administered to the bone defect during flap operation

Trial Locations (6)

Unknown

Kaken Investigational Site 5, Chiyoda-ku

Kaken Investigational Site 2, Matsudo

Kaken Investigational Site 3, Ōta-ku

Kaken Investigational Site 1, Sapporo

Kaken Investigational Site 4, Shinjuku-ku

Kaken Investigational Site 6, Suita

Sponsors
All Listed Sponsors
lead

Kaken Pharmaceutical

INDUSTRY